Literature DB >> 18854866

Mosaic 22q13 deletions: evidence for concurrent mosaic segmental isodisomy and gene conversion.

Maria Clara Bonaglia1, Roberto Giorda, Silvana Beri, Stefania Bigoni, Alberto Sensi, Anna Baroncini, Antonella Capucci, Cristina De Agostini, Rhian Gwilliam, Panos Deloukas, Ian Dunham, Orsetta Zuffardi.   

Abstract

Although 22q terminal deletions are well documented, very few patients with mosaicism have been reported. We describe two new cases with mosaic 22q13.2-qter deletion, detected by karyotype analysis, showing the neurological phenotype of 22q13.3 deletion syndrome. Case 1 represents an exceptional case of mosaicism for maternal 22q13.2-qter deletion (45% of cells) and 22q13.2-qter paternal segmental isodisomy (55% of cells). This complex situation was suspected because cytogenetic, FISH and array-CGH analyses showed the presence of an 8.8 Mb mosaic 22q13.2-qter deletion, whereas microsatellite marker analysis was consistent with maternal deletion without any evidence of mosaic deletion. Molecular analysis led to the definition of very close, but not coincident, deletion and uniparental disomy (UPD) break points. Furthermore, we demonstrated that the segmental UPD arose by gene conversion in the same region. In Case 2, mosaicism for a paternal 8.9 Mb 22q13.2-qter deletion (73% of cells) was detected. In both patients, the level of mosaicism was also verified in saliva samples. We propose possible causative mechanisms for both rearrangements. Although the size of the deletions was quite similar, the phenotype was more severe in Case 2 than in Case 1. As maternal UPD 22 has not been generally associated with any defects and as the size of the deletion is very similar in the two cases, phenotype severity is likely to depend entirely on the degree of mosaicism in each individual.

Entities:  

Mesh:

Year:  2008        PMID: 18854866      PMCID: PMC2682770          DOI: 10.1038/ejhg.2008.195

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  23 in total

1.  Prenatal diagnosis of mosaicism for deletion 22q13.3.

Authors:  M C Phelan; E F Brown; R C Rogers
Journal:  Prenat Diagn       Date:  2001-12       Impact factor: 3.050

2.  Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome.

Authors:  M C Bonaglia; R Giorda; R Borgatti; G Felisari; C Gagliardi; A Selicorni; O Zuffardi
Journal:  Am J Hum Genet       Date:  2001-06-18       Impact factor: 11.025

3.  Prenatal diagnosis of mosaic ring chromosome 22 associated with cardiovascular abnormalities and intrauterine growth restriction.

Authors:  Chih-Ping Chen; Schu-Rern Chern; Tung-Yao Chang; Chen-Chi Lee; Li-Feng Chen; Chin-Yuan Tzen; Wayseen Wang; Chen-Ju Lin; Brian P T Yang; Lawrence S T Yang
Journal:  Prenat Diagn       Date:  2003-01       Impact factor: 3.050

4.  Prenatal diagnosis of mosaicism for a del(22)(q13).

Authors:  M Riegel; A Baumer; J Wisser; J Acherman; A Schinzel
Journal:  Prenat Diagn       Date:  2000-01       Impact factor: 3.050

5.  First postnatal case of mosaic del(22)/r(22).

Authors:  Heike Starke; Beate Mitulla; Volkmar Beensen; Vladimir Trifonov; Nikolai Rubtsov; Anita Heller; Monika Ziegler; Annett Neumann; Uwe Claussen; Thomas Liehr
Journal:  Prenat Diagn       Date:  2003-09       Impact factor: 3.050

6.  Segregation of a 22 ring chromosome in three generations.

Authors:  C Stoll; M P Roth
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

Review 7.  Break-induced replication: a review and an example in budding yeast.

Authors:  E Kraus; W Y Leung; J E Haber
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

8.  Inv dup(22), del(22)(q11) and r(22) in the father of a child with DiGeorge syndrome.

Authors:  A Bergman; E Blennow
Journal:  Eur J Hum Genet       Date:  2000-10       Impact factor: 4.246

9.  Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms.

Authors:  H L Wilson; A C C Wong; S R Shaw; W-Y Tse; G A Stapleton; M C Phelan; S Hu; J Marshall; H E McDermid
Journal:  J Med Genet       Date:  2003-08       Impact factor: 6.318

10.  Selective disruption of muscle and brain-specific BPAG1 isoforms in a girl with a 6;15 translocation, cognitive and motor delay, and tracheo-oesophageal atresia.

Authors:  R Giorda; A Cerritello; M C Bonaglia; S Bova; G Lanzi; E Repetti; S Giglio; C Baschirotto; T Pramparo; L Avolio; R Bragheri; P Maraschio; O Zuffardi
Journal:  J Med Genet       Date:  2004-06       Impact factor: 6.318

View more
  5 in total

Review 1.  Phelan McDermid Syndrome: From Genetic Discoveries to Animal Models and Treatment.

Authors:  Hala Harony-Nicolas; Silvia De Rubeis; Alexander Kolevzon; Joseph D Buxbaum
Journal:  J Child Neurol       Date:  2015-09-08       Impact factor: 1.987

2.  A child with mosaicism for deletion (14)(q11.2q13).

Authors:  Thilini H Gamage; Imaya U H Godapitiya; Shakila Nanayakkara; Rohan W Jayasekara; Vajira H W Dissanayake
Journal:  Indian J Hum Genet       Date:  2012-01

Review 3.  Mosaicism for structural non-centromeric autosomal rearrangements in disease-defined carriers: sex differences in the rearrangements profile and maternal age distributions.

Authors:  Natalia V Kovaleva; Philip D Cotter
Journal:  Mol Cytogenet       Date:  2017-05-19       Impact factor: 2.009

4.  Clinical significance and mechanisms associated with segmental UPD.

Authors:  Peter R Papenhausen; Carla A Kelly; Samuel Harris; Samantha Caldwell; Stuart Schwartz; Andrea Penton
Journal:  Mol Cytogenet       Date:  2021-07-20       Impact factor: 2.009

5.  Molecular mechanisms generating and stabilizing terminal 22q13 deletions in 44 subjects with Phelan/McDermid syndrome.

Authors:  Maria Clara Bonaglia; Roberto Giorda; Silvana Beri; Cristina De Agostini; Francesca Novara; Marco Fichera; Lucia Grillo; Ornella Galesi; Annalisa Vetro; Roberto Ciccone; Maria Teresa Bonati; Sabrina Giglio; Renzo Guerrini; Sara Osimani; Susan Marelli; Claudio Zucca; Rita Grasso; Renato Borgatti; Elisa Mani; Cristina Motta; Massimo Molteni; Corrado Romano; Donatella Greco; Santina Reitano; Anna Baroncini; Elisabetta Lapi; Antonella Cecconi; Giulia Arrigo; Maria Grazia Patricelli; Chiara Pantaleoni; Stefano D'Arrigo; Daria Riva; Francesca Sciacca; Bernardo Dalla Bernardina; Leonardo Zoccante; Francesca Darra; Cristiano Termine; Emanuela Maserati; Stefania Bigoni; Emanuela Priolo; Armand Bottani; Stefania Gimelli; Frederique Bena; Alfredo Brusco; Eleonora di Gregorio; Irene Bagnasco; Ursula Giussani; Lucio Nitsch; Pierluigi Politi; Maria Luisa Martinez-Frias; Maria Luisa Martínez-Fernández; Nieves Martínez Guardia; Anna Bremer; Britt-Marie Anderlid; Orsetta Zuffardi
Journal:  PLoS Genet       Date:  2011-07-14       Impact factor: 5.917

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.